Down regulation of the PEPCK gene can diminish gluconeogenesis and its expression is commonly up-regulated in type 2 diabetes, with FOXO1 known to inhibit PEPCK expression to counteract its effect [38]. This evidence concerns the gene PCK2 and type 2 diabetes mellitus.